We use cookies to provide you a better experience. By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Equity Capital Markets

Stifel ECM delivers a full suite of equity and equity linked products including IPOs, Follow-ons, Converts and SPACs across all of our focus sectors

Equity Capital Markets Group

Industry-Leading Full-Service Equity Capital Markets Group

The Equity Capital Markets Group (ECM) is responsible for originating and executing public and private equity and equity linked offerings as well as SPACs. In 2020, the ECM group managed over 140 equity and equity-linked transactions, including executing over 40 IPOs, raising over $75B. In addition, the ECM team has a leading SPAC business, advising in 2020 on more than 20 transactions within all phases of the Special Purpose Acquisition Company (SPAC) lifecycle, including IPOs, PIPEs, and de-SPAC engagements. The Stifel equity platform brings differentiated institutional access and retail distribution in the US and Internationally.

Optimized solutions to meet each client’s objectives.

Get in touch with Stifel

Notable Transactions

CanWel Building 04-2021

C$ 75,000,000

Follow-on Offering
Building Products | April 2021
Evolus 04-2021

$ 98,325,000

Confidentially Marketed Follow-on Offering
Biopharma | April 2021
SeaSpine Holdings 04-2021

$ 100,912,500

Confidentially Marketed Follow-on Offering
Medtech | April 2021
Karat Packaging 04-2021

$ 72,680,000

Initial Public Offering
Packaging | April 2021
Essential Properties 04-2021
Follow-on Offering
Real Estate | April 2021
Netstreit Corp. 04-2021

$ 177,023,991

Follow-on Offering
Real Estate | April 2021
Maravai Life Sciences 04-2021

$ 646,875,000

Follow-on Offering
Tools & Diagnostics | April 2021
Ionis Pharmaceuticals 04-2021

$ 550,000,000

Convertible Senior Notes
Biopharma | April 2021
Zoo Digital 03-2021

£ 7,454,727

Follow-on Offering
Software | March 2021
ProQR Therapeutics 03-2021

$ 103,500,000

Confidentially Marketed Follow-on Offering
Biopharma | March 2021
Cti Biopharma 03-2021

$ 50,652,000

Confidentially Marketed Follow-on Offering
Biopharma | March 2021
Evofem Biosciences 03-2021

$ 30,000,000

Confidentially Marketed Follow-on Offering
Biopharma | March 2021
Global Partners 03-24-2021

$ 75,000,000

Preferred Stock
Energy & Natural Resources | March 2021
AVEO Oncology 03-2021

$ 48,000,000

Follow-on Offering
Biopharma | March 2021
PhaseBio Pharmaceuticals 03-2021

$ 56,000,000

Confidentially Marketed Follow-on Offering
Biopharma | March 2021
Global Medical REIT 03-2021

$ 99,750,000

Follow-on Offering
Real Estate | March 2021
Soul Community Planet

$ 210,000,000

Private Placement
Real Estate | December 2020
Hennessy Acquisition Corp

$ 323,250,000

Private Investment in Public Equity
Electronics & Industrial Technology | December 2020
KINS Technology

$ 276,000,000

Initial Public Offering
Software | December 2020
AbCellera Biologics 12-2020

$ 555,450,000

Initial Public Offering
Biopharma | December 2020
Hydrofarm Holdings 12-2020
Initial Public Offering
Cannabis | December 2020
GrowGeneration 12-2020

$ 172,500,000

Follow-on Offering
Cannabis | December 2020
Nebula Caravel Acquisition 12-2020

$ 275,000,000

Initial Public Offering
Software | December 2020
Third Point Hellenic Recovery 12-2020

$ 56,600,000

Block Trade
Energy & Natural Resources | December 2020
Novo Resources 12-2020

$ 45,325,000

Block Trade
Metals & Mining | December 2020
IGM Biosciences 12-2020

$ 200,000,000

Follow-on Offering
Biopharma | December 2020
Kura Oncology 12-2020

$ 345,080,500

Follow-on Offering
Biopharma | December 2020
Repligen 12-2020

$ 312,225,000

Follow-on Offering
Tools & Diagnostics | December 2020
Codexis 12-2020

$ 750,000,000

Follow-on Offering
Tools & Diagnostics | December 2020
Silverback Therapeutics 12-2020

$ 277,725,000

Initial Public Offering
Biopharma | December 2020
Montrose Environmental Group 11-2020

€ 134,071,417

Follow-on Offering
Industrial & Environmental Services | November 2020
NeoGames 11-2020

$ 93,987,050

Initial Public Offering
Gaming & Leisure | November 2020
Vital Farms 11-2020

$ 151,250,000

Follow-on Offering
Food & Beverage | November 2020
Marlowe plc 11-2020

€ 30,000,000

Follow-on Offering
Business Services | November 2020
Gaming and Leisure Properties 11-2020

$ 333,500,000

Follow-on Offering
Gaming & Leisure | November 2020
Maravai Life Science, Inc. 11-2020

$ 1,863,000,000

Initial Public Offering
Tools & Diagnostics | November 2020
SQZ Biotechnologies 11-2020

$ 81,176,464

Initial Public Offering
Biopharma | November 2020
Triple Point Social Housing 10-2020

$ 55,000,000

Follow-on Offering
Real Estate | October 2020
Lux Health Tech Acquisition Corp. 10-2020

$ 345,000,000

Initial Public Offering
Medtech | October 2020
Currency volume represents full credit to each underwriter. All transaction announcements appear as a matter of record only. Stifel collectively refers to Stifel, Nicolaus & Company, Incorporated and other affiliated broker-dealer subsidiaries of Stifel Financial Corp.